DiscoverIDBR Infectious Disease Board ReviewStopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD
Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD

Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD

Update: 2024-08-26
Share

Description

A 44-year-old man was diagnosed with Pneumocystis pneumonia as his AIDS-defining illness and begun on antiretroviral therapy with 2 nucleosides and an integrase inhibitor during his hospitalization. He stabilizes and follows up for repeated outpatient visits with an HIV RNA consistently <20 copies/ml and a CD4 cell count of 44 that increased to 163 (at 3 months), 232 (at 6 months), 242 (at 9 months), and was repeated at 243 (at 12 months).




His current medications are: tenofovir alafenamide/emtricitabine, dolutegravir, trimethoprim-sulfa double strength daily, and azithromycin 1200 mg once weekly. He says he’s tired of taking pills and would like to stop some of them.




What do you recommend?


A. Stop tenofovir alafenamide/emtricitabine


B. Stop trimethoprim-sulfa


C. Stop azithromycin


D. Stop trimethoprim-sulfa and azithromycin


E. Continue the current regimen




⁠www.idbrcourse.org/⁠  © 2024 IDBR LLC | All Rights Reserved

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD

Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD

John Bennett, MD / Henry Masur, MD